| Ytd | -50.13% | |
| 1y | 43.00% |
| Open | 0.90 | Prev Close | 0.89 | Low | 0.89 | High | 0.98 | Mkt Cap | 123.74M |
| Vol | 781.69K | Avg Vol | 859.49K | EPS | -0.45 | P/E | N/A | Forward P/E | -2.32 |
| Beta | 1.04 | Short Ratio | 9.26 | Inst. Own | 50.19% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 1.42 | 200-d Avg | 2.19 | 1yr Est | 3.44 |
NAUT News
Gainers Alector (NASDAQ:ALEC) shares increased by 9.7% to $2.59 during Tuesday's after-market s
NAUT is now prioritizing targeted proteoform assays after Broadscale testing failed to support its p
Nautilus Biotechnology, Inc. (NAUT) Q2 2026 Earnings Call Transcript
Gainers OPKO Health (NASDAQ:OPK) shares increased by 34.7% to $1.67 during Tuesday's regular se
Nautilus Biotechnology NASDAQ: NAUT said it is shifting a significant share of its research and deve
SEATTLE, July 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pi
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the a
SEATTLE, July 08, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”
Oversold health care stocks: EVMN, NNNN, NAUT. RSI <30 shows they may be undervalued. EVMN drop
Tom Yeung here with your Sunday Digest.
Nautilus Biotechnology, Inc. (NAUT) Q1 2026 Earnings Call Transcript
SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company p
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.12) per share which beat the a
The real brain computer interface opportunity isn't in the headlines. These 10 stocks are building t
U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market
• Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for dev
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcri
Guggenheim analyst Subbu Nambi maintains Nautilus Biotechnology (NASDAQ:NAUT) with a Buy and rais
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”
• Buck Institute's deployment of Nautilus' instrument generates tau proteoform data, providing exter
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q3 2025 Earnings Call October 28, 2025 8:30 AM EDT Compa
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Morgan Stanley 23rd Annual Global Healthcare Conference
Nautilus Biotechnology, Inc. (NASDAQ:NAUT ) Q2 2025 Earnings Call July 31, 2025 8:30 AM ET Company P
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”
SEATTLE, July 15, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a
Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third q
U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Frid
U.S. stocks traded down this morning with the Nasdaq Composite falling more than 101 points on Frida
Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the comp
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin
On Monday, 297 companies reached new 52-week lows.
During Friday's trading, 293 companies set new 52-week lows.
Monday saw 196 companies set new 52-week lows.